First detection of foot-and-mouth disease virus O/ME-SA/ Ind2001e sublineage in Jordan

Foot-and-Mouth Disease Virus Serotype O Exhibits Phenomenal Genetic Lineage Diversity in India during 2018-2022

In India, widespread foot-and-mouth disease (FMD) outbreaks occurred in 2021. The objective of this study was to identify genetic lineages and evaluate the antigenic relationships of FMD virus (FMDV) isolates gathered from outbreaks reported between 2019 and 2022. Our study shows that the lineages O/ME-SA/Ind2001e and the O/ME-SA/Cluster-2018 were both responsible for the FMD outbreaks on an epidemic scale during 2021. This observation is in contrast to earlier findings that suggested epidemic-scale FMD outbreaks in India are often connected to a single genetic lineage. Additionally, we report here the identification of the O/ME-SA/PanAsia-2/ANT10 sub-lineage in India for the first time, which was connected to two intermittent outbreaks in Jammu and Kashmir. The current study demonstrates that the O/ME-SA/ind2001e lineage has a strong presence outside of the Indian subcontinent. Furthermore, the O/ME-SA/Cluster-2018 was observed to have a wider geographic distribution than previously, and like the O/ME-SA/Ind2001d and O/ME-SA/Ind2001e lineages in the past, it may eventually spread outside of its geographic niche. For O/ME-SA/Ind2001e and O/ME-SA/Cluster-2018, the predicted substitution rate for the VP1 region was 6.737 × 10^-3 and 8.257 × 10^-3 nt substitutions per site per year, respectively. The time of the most recent common ancestor of the O/ME-SA/Ind2001e and O/ME-SA/Cluster-2018 strains suggests that the viruses possibly emerged during 2003-2011 and 2009-2017, respectively. Recent sightings of the O/ME-SA/PanAsia2/ANT10 virus in India and the O/ME-SA/Ind2001e virus in Pakistan point to possible cross-border transit of the viruses. The results of a two-dimensional viral neutralization test revealed that all of the field isolates were antigenically matched to the currently used Indian vaccine strain O INDR2/1975. These results suggest that the serotype O vaccine strain can protect against outbreaks brought on by all three circulating lineages.

Common diseases of cattle in Jordan: A retrospective study (2015-2021)

Background and Aim

In many developing countries, infectious and non-infectious diseases remain a major hurdle in achieving satisfactory status related to animal health, productivity, and welfare. In Jordan, there are no comprehensive reports describing the most common diseases involving different body systems in different age groups of cattle. Therefore, this retrospective study was designed to report the frequencies of various infectious and non-infectious diseases and their distribution according to sex, age, and body system in cattle in Jordan.

Materials and Methods

Case medical records of cattle presented for clinical evaluation to the Veterinary Health Center of the Faculty of Veterinary Medicine at Jordan University of Science and Technology between January 2015 and December 2021 were used in this study. The data were categorized based on sex (female vs. male), body system involved in the disease process, nature of the disease process (infectious vs. non-infectious), and age (pre-weaning [<2 months of age], 2 months-2 years of age, and older than 2 years of age). Descriptive analysis was performed to report the frequencies, averages, and range values using Excel spreadsheets.

Results

Medical records of 513 cattle cases were used in the study. All cattle belonged to the Holstein-Friesian dairy breed. The majority of cases were female (91%). The age of animals ranged between 1 day and 8 years. According to age groups, there were 52%, 27%, and 16% of cases older than 2 years, 2 months-2 years, and pre-weaning (<2 months), respectively. Among males and females, the majority of cases were diagnosed with gastrointestinal diseases (30%), followed by udder/teat diseases (18%), reproductive and obstetrical diseases (16%), and respiratory diseases (11%). Other body systems involved in disease processes were metabolic (7%), musculoskeletal (6%), cardiovascular/circulatory (4%), multiple systems (3%), nervous (2%), ear/eye (2%), and skin (1%).

Conclusion

Results of this study provide valuable information on the most likely diagnostic list of diseases involving various body systems of different age groups in cattle in Jordan. This information could serve as a clinical guideline for field diagnosis of cattle diseases and provide an accurate estimate of the current status of cattle welfare, health, and husbandry practices in Jordan.

Development and serology based efficacy assessment of a trivalent foot-and-mouth disease vaccine

Foot-and-mouth disease (FMD) is a highly contagious disease of cloven-hoofed animals throughout the world. The endemicity of this disease in Bangladesh has been causing high economic loss and an impediment to the full potential surge of livestock industries. In Bangladesh, vaccination using imported or locally produced FMD vaccines is the existing practice of controlling the disease, although vaccine failure cases are very common. Hence, to address the problem, the present study was envisaged to develop an effective FMD vaccine tailored to the circulating indigenous foot-and-mouth disease virus (FMDV) strains. Three local circulating FMDVs O/BAN/TA/Dh-301/2016 (MK088170.1), A/BAN/CH/Sa-304/2016 (MK088171.1) and Asia1/BAN/DH/Sa-318/2018 (MH457186.1) isolates were selected as vaccine strains based on recent epidemiology, genetic and antigenic analyses. These serotype O, A and Asia1 vaccine strains showed strong antigenic relationship (r1 > 0.3) with 100% to 75% of the respective circulating viruses. The candidate viruses were successfully inactivated by 3.0 mM binary ethylenimine within 7-10 h after the onset of inactivation. Extrapolation of inactivation kinetics confirmed < 1 log₁₀ TCID₅₀ in a 10000-liter batch liquid preparation after 24 h inactivation cycle. The inactivated virus particles were significantly (p < 0.05) concentrated and the trivalent vaccine was formulated using 6 µg per dose per serotype antigen payload. The trivalent vaccine was administered in divided doses in different groups of cattle. All doses of the vaccine elicited significantly (p < 0.05) higher levels of antibodies as early as 14-day post-vaccination (dpv) and peak antibody titers were achieved in 28 dpv. The 'full dose' (6.0 µg per dose per serotype) vaccine elicited antibody titers expected to confer protection in 100% cattle of the respective group and maintained such level of antibodies beyond 180 dpv. Thus, the trivalent FMD vaccine prepared with 6.0 µg antigen per dose per serotype of the selected candidate viruses will confer protection against circulating FMDVs of Bangladesh and its neighboring countries.